Audit 301098

FY End
2023-06-30
Total Expended
$479.62M
Findings
4
Programs
161
Organization: University of Rochester (NY)
Year: 2023 Accepted: 2024-03-29

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
390192 2023-001 - - AB
390193 2023-002 - - L
966634 2023-001 - - AB
966635 2023-002 - - L

Programs

ALN Program Spent Major Findings
84.268 Federal Direct Student Loans $53.36M Yes 0
93.498 Covid 19 - Provider Relief Fund and American Rescue Plan (arp) Distribution $20.33M Yes 2
93.855 Allergy, Immunology, and Transplantation Research $18.45M Yes 0
93.853 Extramural Research Programs in the Neuroscience and Neurological Disorders $17.78M Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Extramural Research $8.95M Yes 0
93.113 Biological Response to Environmental Health Hazards $8.27M Yes 0
84.063 Federal Pell Grant Program $6.15M Yes 0
93.399 Cancer Control $6.00M Yes 0
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $4.89M Yes 0
47.041 Engineering Grants $3.26M Yes 0
47.070 Computer and Informational Science and Engineering $2.50M Yes 0
93.317 Emerging Infections Programs $2.18M Yes 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $1.96M Yes 0
11.619 Arrangements for Interdisciplinary Research Infrastructure $1.96M Yes 0
12.800 Air Force Defense Research Sciences Program $1.94M Yes 0
93.185 Immunization Research, Demonstration, Public Info and Education Training $1.81M Yes 0
93.829 Covid 19 - Section 223 Demonstration Programs to Improve Comm Mental Hlth Svcs $1.68M Yes 0
93.840 Translation and Implementation Science Research for Heart Lung Blood Diseases and Sleep Disorders $1.63M Yes 0
84.033 Federal Work-Study Program $1.52M Yes 0
81.135 Advanced Research Projects - Energy $1.26M Yes 0
93.837 Cardiovascular Diseases Research $1.22M Yes 0
93.351 Research Infrastructure Programs $1.19M Yes 0
93.398 Cancer Research Manpower $1.08M Yes 0
93.969 Covid 19 - International Research and Research Training $1.08M - 0
93.135 Center for Research and Demonstration for Health Promotion and Disease Prevention $1.02M Yes 0
84.007 Federal Supplemental Educational Opportunity Grants $792,094 Yes 0
93.632 University Centers for Excellence in Develop Disabilities, Education, Research and Service $753,478 - 0
93.045 Special Programs for the Aging_title Iii, Part C_nutrition Services $677,611 - 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $649,601 Yes 0
43.003 Exploration $630,281 Yes 0
93.976 International Research and Research Training $587,133 Yes 0
84.047 Trio - Upward Bound $580,365 - 0
93.110 Maternal and Child Health Federal Consolidated Programs $559,817 - 0
93.958 Block Grants for Community Mental Health Services $533,877 Yes 0
93.103 Food and Drug Administration Research $524,370 Yes 0
93.884 Grants for Training in Primary Care Medicine and Dentistry $502,883 Yes 0
12.431 Basic Scientific Research $482,874 Yes 0
84.044 Trio - Talent Search $456,427 - 0
12.RD Unknown $448,740 Yes 0
93.859 Biomedical Research and Research Training $346,510 Yes 0
47.079 Office of International Science and Engineering $344,083 Yes 0
47.084 Unknown $325,207 Yes 0
93.186 Health Resources and Services Association $317,086 Yes 0
12.910 Research and Technology Development $313,869 Yes 0
93.310 Trans-Nih Research Support $271,713 Yes 0
12.420 Military Medical Research and Development $263,874 Yes 0
84.324A Unknown $262,297 - 0
97.036 Covid 19 - Disaster Grants - Public Assistance (presidentially Declared Disasters) $252,980 Yes 0
93.826 Closing the Gap Between Standards Development and Implementation $239,764 Yes 0
93.839 Blood Diseases and Resources Research $236,802 Yes 0
93.917 Hiv Care Formula Grants $225,098 Yes 0
93.354 Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response $222,163 Yes 0
93.732 Mental and Behavioral Health Education Training Grants $214,558 - 0
84.042A Trio - Student Support Services $209,137 - 0
93.247 Advanced Nursing Education Workforce Grant Program $198,730 - 0
84.217A Trio - McNair Post Baccalaureate Achievement $173,206 - 0
93.172 Human Genome Research $161,909 Yes 0
93.279 Drug Abuse and Addiction Research Programs $160,267 Yes 0
84.217 Trio - McNair Post Baccalaureate Achievement $157,220 - 0
93.877 Autism Collaboration, Accountability, Research, Education, and Support $152,822 Yes 0
45.161 Promotion of the Humanities Research $134,053 - 0
93.323 Epidemiology and Laboratory Capacity for Infectious Diseases (elc) $132,658 Yes 0
81.049 Office of Science Financial Assistance Program $131,324 Yes 0
93.989 Senior International Fellowships $121,428 Yes 0
93.RD Unknown $119,029 Yes 0
93.944 Human Immunodeficiency Virus (hiv)/acquired Immunodeficiency Virus Syndrome (aids) Surveillance $118,774 Yes 0
93.044 Special Programs for the Aging_title Iii, Part B_grants for Supportive Services and Senior Centers $117,566 - 0
93.137 Community Programs to Improve Minority Health Grant Program $112,139 Yes 0
66.RD Unknown $108,023 Yes 0
84.200 Graduate Assistance in Areas of National Need $100,031 - 0
93.867 Vision Research $97,652 Yes 0
93.630 Developmental Disabilities Basic Support and Advocacy Grants $93,160 Yes 0
93.350 National Center for Advancing Translational Sciences $92,667 Yes 0
93.052 National Family Caregiver Support, Title Iii, Part E $88,786 - 0
47.075 Social, Behavioral, and Economic Sciences $87,308 Yes 0
12.351 Basic Scientific Research - Combating Weapons of Mass Destruction $84,161 Yes 0
10.310 Agriculture and Food Research Initiative $83,338 Yes 0
93.250 Geriatric Academic Career Awards $80,657 Yes 0
47.083 Integrative Activities $80,385 Yes 0
14.906 Healthy Homes Technical Studies Grants $76,629 - 0
47.050 Geosciences $75,836 Yes 0
93.364 Nursing Student Loans $73,167 Yes 0
93.889 National Bioterrorism Hospital Preparedness Program $72,500 - 0
12.630 Basic, Applied, and Advanced Research in Science and Engineering $72,149 Yes 0
93.989 International Research and Research Training $66,165 Yes 0
47.070 Computer and Information Science and Engineering $60,649 Yes 0
93.866 Aging Research $59,011 Yes 0
81.113 Defense Nuclear Nonproliferation Research $58,674 Yes 0
20.616 National Priority Safety Programs $58,528 - 0
93.142 Niehs Hazardous Waste Worker Health and Safety Training $58,391 Yes 0
93.838 Lung Diseases Research $58,335 Yes 0
93.393 Cancer Cause and Prevention Research $53,809 Yes 0
64.U05 Unknown $53,416 - 0
94.013 Volunteers in Service to America $52,941 - 0
43.RD Unknown $52,716 Yes 0
93.394 Cancer Detection and Diagnosis Research $50,953 Yes 0
64.U04 Unknown $49,340 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $48,774 Yes 0
93.583 Refugee and Entrant Assistance_wilson/fish Program $47,979 Yes 0
93.213 Research and Training in Complementary and Integrative Health $47,404 Yes 0
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $46,637 Yes 0
45.312 National Leadership Grants $38,814 - 0
43.012 Space Technology $35,410 Yes 0
45.169 Promotion of the Humanities Office of Digital Humanities $34,815 - 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $34,216 Yes 0
45.301 Museums for America $31,861 - 0
93.834 Capacity Building Assistance (cba) for High-Impact Hiv Prevention $29,968 - 0
64.U03 Unknown $24,764 - 0
47.076 Education and Human Resources $24,376 Yes 0
93.396 Cancer Biology Research $24,103 Yes 0
93.395 Cancer Treatment Research $22,612 Yes 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $22,339 Yes 0
84.022A Overseas Programs - Doctoral Dissertation Research Abroad $21,722 - 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $21,007 Yes 0
64.U02 Unknown $20,690 - 0
93.242 Mental Health Research Grants $20,650 Yes 0
93.397 Cancer Centers Support Grants $20,585 Yes 0
81.RD Unknown $19,346 Yes 0
93.924 Ryan White Hiv/aids Dental Reimbursement and Community Based Dental Partnership Grants $18,918 Yes 0
93.104 Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances (sed) $17,091 Yes 0
93.865 Child Health and Human Development Extramural Research $16,830 Yes 0
93.361 Nursing Research $16,096 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $14,598 Yes 0
81.112 Stewardship Science Grant Program $14,571 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $14,202 Yes 0
93.173 Research Related to Deafness and Communication Disorders $13,192 Yes 0
93.053 Nutrition Services Incentive Program $12,417 - 0
47.049 Mathematical and Physical Sciences $12,084 Yes 0
93.113 Environmental Health $10,486 Yes 0
45.025 Promotion of the Arts_partnership Agreements $10,333 - 0
93.073 Birth Defects and Developmental Disabilities - Prevention and Surveillance $10,331 Yes 0
47.084 Nsf Technology, Innovation, and Partnerships $10,079 Yes 0
43.008 Education $10,031 Yes 0
47.041 Engineering $9,603 Yes 0
21.027 Coronavirus State and Local Fiscal Recovery Funds $9,133 - 0
93.855 Allergy, Immunology and Transplantation Research $7,920 Yes 0
47.074 Biological Sciences $7,147 Yes 0
93.273 Alcohol Research Programs $5,380 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $4,524 Yes 0
45.162 Promotion of the Humanities Teaching and Learning Resources and Curriculum Dev $4,022 - 0
93.939 Hiv Prevention Activities, Non-Governmental Organization Based $3,911 - 0
93.117 Preventive Medicine Residency $3,858 Yes 0
93.359 Nurse Education, Practice Quality and Retention Grants $3,697 Yes 0
47.078 Polar Programs $3,256 Yes 0
98.001 Usaid Foreign Assistance for Programs Overseas $2,047 - 0
93.307 Minority Health and Health Disparities Research $1,329 Yes 0
93.994 Maternal and Child Health Services Block Grant to the States $534 - 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $406 Yes 0
43.001 Science $338 Yes 0
93.121 Oral Diseases and Disorders Research $11 Yes 0
84.038 Federal Perkins Loan Program $0 Yes 0
66.500 Unknown $-334 Yes 0
93.631 Developmental Disabilities Projects of National Significance $-794 Yes 0
93.103 Food and Drug Administration_research $-1,809 Yes 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $-4,573 Yes 0
11.307 Economic Adjustment Assistance $-4,756 - 0
64.U01 Unknown $-5,127 - 0
45.024 Promotion of the Arts, Grants to Organizations and Individuals $-15,749 - 0
81.135 Advanced Research Projects Agency - Energy $-20,023 Yes 0
93.059 Training in General, Pediatric, and Public Health Dentistry $-42,041 Yes 0
12.300 Basic and Applied Scientific Research $-160,360 Yes 0

Contacts

Name Title Type
F27KDXZMF9Y8 Jeffery Sullivan Auditee
5852751648 Tim Weld Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the expenditures of the University of Rochester and its related entities (the “University”) under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented on the accrual basis of accounting, which is in accordance with the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only the federal award activity of the University, it is not intended to and does not present the financial position, changes in net assets and cash flows of the University. De Minimis Rate Used: N Rate Explanation: See Note 3. The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the expenditures of the University of Rochester and its related entities (the “University”) under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented on the accrual basis of accounting, which is in accordance with the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only the federal award activity of the University, it is not intended to and does not present the financial position, changes in net assets and cash flows of the University. For purposes of the Schedule, federal awards include all grants, contracts and similar agreements entered into directly between the University and agencies and departments of the federal government and all sub-awards to the University by nonfederal organizations pursuant to federal grants, contracts and similar agreements. Negative numbers in the Schedule represent adjustments to amounts reported in prior years in the normal course of business. Federal Assistance Numbers and pass-through numbers are provided when available.
Title: Loan Programs Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the expenditures of the University of Rochester and its related entities (the “University”) under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented on the accrual basis of accounting, which is in accordance with the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only the federal award activity of the University, it is not intended to and does not present the financial position, changes in net assets and cash flows of the University. De Minimis Rate Used: N Rate Explanation: See Note 3. The Federal Perkins Loan Program and the Federal Nursing Student Loan Program are administered directly by the University and balances and transactions relating to these programs are included in the University’s consolidated financial statements. The amount of Federal Perkins loans and Federal Nursing Student loans outstanding at June 30, 2023 totaled $3,959,596 and $742,892, respectively. Loans outstanding at the beginning of the year and loans made during the year are included in the federal expenditures presented in the Schedule.
Title: Facilities and Administrative Cost Rates Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the expenditures of the University of Rochester and its related entities (the “University”) under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented on the accrual basis of accounting, which is in accordance with the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only the federal award activity of the University, it is not intended to and does not present the financial position, changes in net assets and cash flows of the University. De Minimis Rate Used: N Rate Explanation: See Note 3. The University had predetermined facilities and administrative cost rates for the year ended June 30, 2023 under a rate agreement with the Department of Health and Human Services, the University’s federal cognizant agency. The base rate for on-campus research was 54.0% for fiscal 2023. The base rate for off-campus research was 27.0% for fiscal 2023. The University does not utilize the 10% de minimis cost rate described in section 200.414 of Uniform Guidance.
Title: CARES ACT Providor Relief Funds Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the expenditures of the University of Rochester and its related entities (the “University”) under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented on the accrual basis of accounting, which is in accordance with the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only the federal award activity of the University, it is not intended to and does not present the financial position, changes in net assets and cash flows of the University. De Minimis Rate Used: N Rate Explanation: See Note 3. The Schedule includes grant activity related to the Department of Health and Human Services ("HHS") Provider Relief Fund and American Rescue Plan (ARP) Distribution Assistance Listing Number 93.498.  As required based on guidance in the 2023 OMB Compliance Supplement, the Schedule includes all Period 4 funds received between July 1, 2021 and December 31, 2021 and expended by December 31, 2022 and Period 5 funds received between January 1, 2022 to June 30, 2022 and expended by June 30, 2023 as reported to HRSA via the Provider Relief Funding Reporting Portal. The Schedule thus includes $20,328,583 of reportable Provider Relief Payments which includes $17,687,445 of direct expenditures and $2,641,138 in lost revenue.  Given the timing covered by Periods 4 and 5, certain expenses were reflected in the University's fiscal year 2022 consolidated financial statements. Additionally, lost revenue does not represent an expenditure in the University’s consolidated financial statements and thus is a reconciling item between the federal expenses in the University's consolidated financial statements and the amount included on the Schedule.
Title: Federal Emergency Management Agency (FEMA) Public Assistance Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) summarizes the expenditures of the University of Rochester and its related entities (the “University”) under programs of the federal government for the year ended June 30, 2023. The information in the Schedule is presented on the accrual basis of accounting, which is in accordance with the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only the federal award activity of the University, it is not intended to and does not present the financial position, changes in net assets and cash flows of the University. De Minimis Rate Used: N Rate Explanation: See Note 3. The University applied for reimbursement of certain expenses related to the COVID-19 pandemic  under Assistance Listing number 97.036, FEMA Disaster Grants - Public Assistance (Presidentially Declared Disasters) through the New York State Division of Homeland Security and Emergency Services. Expenditures are reflected in the Schedule  in the year in which a project application is obligated. The Schedule thus includes $2,411,328 of expenditures which were obligated in fiscal year 2023 and incurred prior to fiscal year 2023, and therefore represents a reconciling item between the federal expenses in the University’s financial statements and the amount included on the Schedule.

Finding Details

2023-001: (A) (B) Unallowed COVID-19 expenditures reported within the Health Resources Services Administration (HRSA) Provider Relief Fund (PRF) Portal, Program: COVID-19 - Provider Relief Fund and American Rescue Plan (ARP) Distribution, Assistance Listing Number: 93.498, Agency: Department of Health and Human Services (HHS), Award Year: 1/1/2020-6/30/2023, Award Number: Not available Criteria Law (Pub. L. No. 116-136, 134 Stat. 563 and Pub. L. No. 116-139, 134 Stat. 622 and 623) notes that PRFs should be used to prevent, prepare for, and respond to coronavirus, domestically or internationally, for necessary expenses to reimburse, through grants or other mechanisms, eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. Additionally, these funds may not be used to reimburse expenses or losses that have been reimbursed from other sources or that other sources are obligated to reimburse. Condition The University of Rochester and Related Entities had 11 Period 4 submissions and 2 Period 5 submissions into the HRSA portal. Period 4 reporting was completed by the following entities: 1. University of Rochester, 2. UR Medicine Home Care, Certified Services, Inc., 3. St. James Hospital, 4. The Frederick Ferris Thompson Hospital, 5. MM Ewing Continuing Care Center, 6. Nicholas H. Noyes Memorial Hospital, 7. Memorial Hospital of William F and Gertrude F Jones Inc. 8. The Highlands Living Center Inc., 9. Highland Hospital of Rochester,10. Meadows at Westfall, Inc., and 11. FFT Senior Communities, Inc. Period 5 reporting was completed by the following entities: 1. UR Medicine Home Care, Certified Services, and 2. Highland Community Development Corp (d/b/a Highlands at Pittsford). From the detailed listing of expenses across the Period 4 HRSA submissions, we performed allowability testing of the “Unreimbursed Expenses Attributable to Coronavirus” in accordance with the Department of Health and Human Services (HHS) terms and conditions. The following table illustrates COVID-19 expenditures overstated (unallowable expenditure) in the Period 4 HRSA submissions by entity, by quarter and in total on a consolidated basis across the organization. Entities Other PRF Expenses Quarter 3 (July - September 2021) Quarter 4 (October - December 2021) Quarter 1 (January - March 2022) Total Overstated expenses UR Medicine Home Care Personnel 445 445 Nicholas H. Noyes Memorial Hospital Supplies 104,368 104,368 St. James Hospital Personnel 240 98,279 98,519 Total - Overstated expenses $ 240 $ 98,724 $ 104,368 $ 203,332 Cause The causes of the issues noted above were due to a lack of consistency in tracking and reviewing COVID-19 expenditures for inclusion in the Period 4 reporting across the organization. Effect University of Rochester and Related Entities’ Period 4 HRSA Reporting Portal submissions inaccurately captured total “Other PRF Expenses”. Questioned Costs UR Medicine Home Care had $445 of unallowable costs, however reported $1,362,892 million of unused lost revenues on the Phase 4 HRSA report. Nicholas H. Noyes Memorial Hospital had $104,368 of unallowable costs, however reported $1,818,103 of unused lost revenues on the Phase 4 HRSA report. St. James Hospital had $98,519 of unallowable costs, however reported lost revenue available to be used in the current reporting period was $203,524. As there were sufficient lost revenues for each entity, there are no questioned costs associated with this finding. Recommendation We recommend (should there be future funding) management ensure that the organization-wide policy for tracking and reviewing COVID-19 expenditures is implemented more consistently across entities. This will help ensure completeness and accuracy of future federal report and/or HRSA Reporting portal submissions. Additionally, we recommend management communicate the errors noted in the submissions to HRSA and request advice for how to correct this error.
2023-002: (L) Reporting of Unreimbursed Expenses Attributable to Coronavirus and Lost Revenues, within the Health Resources Services Administration (HRSA) Provider Relief Fund Portal, Program: COVID-19 - Provider Relief Fund and American Rescue Plan (ARP) Distribution, Assistance Listing Number: 93.498, Agency: Department of Health and Human Services (HHS), Award Year: 1/1/2023-3/31/2023, Award Number: Not available Criteria Law (Pub. L. No. 116-136, 134 Stat. 563 and Pub. L. No. 116-139, 134 Stat. 622 and 623) notes that PRFs should be used to prevent, prepare for, and respond to coronavirus, domestically or internationally, for necessary expenses to reimburse, through grants or other mechanisms, eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. Additionally, these funds may not be used to reimburse expenses or losses that have been reimbursed from other sources or that other sources are obligated to reimburse. Condition Through testing of Period 4 HRSA portal submissions, we identified the following: St James Hospital: • Personnel costs of $466,729 were all reported in quarter 3 of 2021 on the Phase 4 HRSA report. These costs related to incentive pay and were expensed from July 2021 through June 2022, and should have been allocated between Q3 2021 – Q2 2022 instead of all in Q3 2021. Costs were determined to be allowable, reporting error only. The reporting for the quarters noted below were over/under stated by the following amounts due to this: Quarter 3(July - September 2021) Quarter 4(October - December 2021) Quarter 1(January - March 2022) Quarter 2(April-June 2022) Total Over (Under) stated $376,523 $(184,184) $(108,609) $(83,730) $0 • Lost revenue calculation inaccurately overstated actual 2021 revenues as management did not include actual revenue net of bad debt expense in the quarterly totals for calendar year 2021. The Phase 4 HRSA report included no eligible lost revenue for 2021, and using the corrected amount of revenue net of bad debt expense does not change this conclusion. The report was corrected to properly state actual 2021 revenue. Memorial Hospital of William F and Gertrude F Jones Inc.: • Supply costs related to COVID-19 tests were reported on an equal allocation across quarters verses in actual amounts across quarters on the Phase 4 HRSA report. These costs were aggregated in total and then reported per each quarter based on an equal allocation, and should have been reported per each quarter based on the actual expenditure amount incurred in the respective quarter. Costs were determined to be allowable, reporting error only. The reporting for the quarters noted below were over/under stated by the following amounts due to this: Quarter 3(July - September 2021) Quarter 4(October - December 2021) Quarter 1(January - March 2022) Quarter 2 (April-June 2022) Quarter 3(July – September 2022) Quarter 4 (October-December 2022) Total Over (Under) stated $83,130 $850 $21,930 $(105,910) $29,227 $(29,227) $0 Cause The causes of the issues noted above were due to a lack of consistency in tracking and reviewing COVID-19 expenditures for inclusion in the Period 4 reporting across the organization. Effect University of Rochester and Related Entities’ Period 4 HRSA Reporting Portal submissions inaccurately captured total “Personnel” and “Fringe Benefits” for PRF expenses, and inaccurately captured total revenues which are utilized to report lost revenues for the period. Questioned Costs None noted. Recommendation We recommend (should there be future funding) management ensure that the organization-wide policy for reviewing HRSA Reporting portal submissions is implemented more consistently across entities. This will help ensure completeness and accuracy of future federal report and/or HRSA Reporting portal submissions. Additionally, we recommend management communicate the errors noted in the submissions to HRSA and request advice for how to correct this error.
2023-001: (A) (B) Unallowed COVID-19 expenditures reported within the Health Resources Services Administration (HRSA) Provider Relief Fund (PRF) Portal, Program: COVID-19 - Provider Relief Fund and American Rescue Plan (ARP) Distribution, Assistance Listing Number: 93.498, Agency: Department of Health and Human Services (HHS), Award Year: 1/1/2020-6/30/2023, Award Number: Not available Criteria Law (Pub. L. No. 116-136, 134 Stat. 563 and Pub. L. No. 116-139, 134 Stat. 622 and 623) notes that PRFs should be used to prevent, prepare for, and respond to coronavirus, domestically or internationally, for necessary expenses to reimburse, through grants or other mechanisms, eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. Additionally, these funds may not be used to reimburse expenses or losses that have been reimbursed from other sources or that other sources are obligated to reimburse. Condition The University of Rochester and Related Entities had 11 Period 4 submissions and 2 Period 5 submissions into the HRSA portal. Period 4 reporting was completed by the following entities: 1. University of Rochester, 2. UR Medicine Home Care, Certified Services, Inc., 3. St. James Hospital, 4. The Frederick Ferris Thompson Hospital, 5. MM Ewing Continuing Care Center, 6. Nicholas H. Noyes Memorial Hospital, 7. Memorial Hospital of William F and Gertrude F Jones Inc. 8. The Highlands Living Center Inc., 9. Highland Hospital of Rochester,10. Meadows at Westfall, Inc., and 11. FFT Senior Communities, Inc. Period 5 reporting was completed by the following entities: 1. UR Medicine Home Care, Certified Services, and 2. Highland Community Development Corp (d/b/a Highlands at Pittsford). From the detailed listing of expenses across the Period 4 HRSA submissions, we performed allowability testing of the “Unreimbursed Expenses Attributable to Coronavirus” in accordance with the Department of Health and Human Services (HHS) terms and conditions. The following table illustrates COVID-19 expenditures overstated (unallowable expenditure) in the Period 4 HRSA submissions by entity, by quarter and in total on a consolidated basis across the organization. Entities Other PRF Expenses Quarter 3 (July - September 2021) Quarter 4 (October - December 2021) Quarter 1 (January - March 2022) Total Overstated expenses UR Medicine Home Care Personnel 445 445 Nicholas H. Noyes Memorial Hospital Supplies 104,368 104,368 St. James Hospital Personnel 240 98,279 98,519 Total - Overstated expenses $ 240 $ 98,724 $ 104,368 $ 203,332 Cause The causes of the issues noted above were due to a lack of consistency in tracking and reviewing COVID-19 expenditures for inclusion in the Period 4 reporting across the organization. Effect University of Rochester and Related Entities’ Period 4 HRSA Reporting Portal submissions inaccurately captured total “Other PRF Expenses”. Questioned Costs UR Medicine Home Care had $445 of unallowable costs, however reported $1,362,892 million of unused lost revenues on the Phase 4 HRSA report. Nicholas H. Noyes Memorial Hospital had $104,368 of unallowable costs, however reported $1,818,103 of unused lost revenues on the Phase 4 HRSA report. St. James Hospital had $98,519 of unallowable costs, however reported lost revenue available to be used in the current reporting period was $203,524. As there were sufficient lost revenues for each entity, there are no questioned costs associated with this finding. Recommendation We recommend (should there be future funding) management ensure that the organization-wide policy for tracking and reviewing COVID-19 expenditures is implemented more consistently across entities. This will help ensure completeness and accuracy of future federal report and/or HRSA Reporting portal submissions. Additionally, we recommend management communicate the errors noted in the submissions to HRSA and request advice for how to correct this error.
2023-002: (L) Reporting of Unreimbursed Expenses Attributable to Coronavirus and Lost Revenues, within the Health Resources Services Administration (HRSA) Provider Relief Fund Portal, Program: COVID-19 - Provider Relief Fund and American Rescue Plan (ARP) Distribution, Assistance Listing Number: 93.498, Agency: Department of Health and Human Services (HHS), Award Year: 1/1/2023-3/31/2023, Award Number: Not available Criteria Law (Pub. L. No. 116-136, 134 Stat. 563 and Pub. L. No. 116-139, 134 Stat. 622 and 623) notes that PRFs should be used to prevent, prepare for, and respond to coronavirus, domestically or internationally, for necessary expenses to reimburse, through grants or other mechanisms, eligible health care providers for health care related expenses or lost revenues that are attributable to coronavirus. Additionally, these funds may not be used to reimburse expenses or losses that have been reimbursed from other sources or that other sources are obligated to reimburse. Condition Through testing of Period 4 HRSA portal submissions, we identified the following: St James Hospital: • Personnel costs of $466,729 were all reported in quarter 3 of 2021 on the Phase 4 HRSA report. These costs related to incentive pay and were expensed from July 2021 through June 2022, and should have been allocated between Q3 2021 – Q2 2022 instead of all in Q3 2021. Costs were determined to be allowable, reporting error only. The reporting for the quarters noted below were over/under stated by the following amounts due to this: Quarter 3(July - September 2021) Quarter 4(October - December 2021) Quarter 1(January - March 2022) Quarter 2(April-June 2022) Total Over (Under) stated $376,523 $(184,184) $(108,609) $(83,730) $0 • Lost revenue calculation inaccurately overstated actual 2021 revenues as management did not include actual revenue net of bad debt expense in the quarterly totals for calendar year 2021. The Phase 4 HRSA report included no eligible lost revenue for 2021, and using the corrected amount of revenue net of bad debt expense does not change this conclusion. The report was corrected to properly state actual 2021 revenue. Memorial Hospital of William F and Gertrude F Jones Inc.: • Supply costs related to COVID-19 tests were reported on an equal allocation across quarters verses in actual amounts across quarters on the Phase 4 HRSA report. These costs were aggregated in total and then reported per each quarter based on an equal allocation, and should have been reported per each quarter based on the actual expenditure amount incurred in the respective quarter. Costs were determined to be allowable, reporting error only. The reporting for the quarters noted below were over/under stated by the following amounts due to this: Quarter 3(July - September 2021) Quarter 4(October - December 2021) Quarter 1(January - March 2022) Quarter 2 (April-June 2022) Quarter 3(July – September 2022) Quarter 4 (October-December 2022) Total Over (Under) stated $83,130 $850 $21,930 $(105,910) $29,227 $(29,227) $0 Cause The causes of the issues noted above were due to a lack of consistency in tracking and reviewing COVID-19 expenditures for inclusion in the Period 4 reporting across the organization. Effect University of Rochester and Related Entities’ Period 4 HRSA Reporting Portal submissions inaccurately captured total “Personnel” and “Fringe Benefits” for PRF expenses, and inaccurately captured total revenues which are utilized to report lost revenues for the period. Questioned Costs None noted. Recommendation We recommend (should there be future funding) management ensure that the organization-wide policy for reviewing HRSA Reporting portal submissions is implemented more consistently across entities. This will help ensure completeness and accuracy of future federal report and/or HRSA Reporting portal submissions. Additionally, we recommend management communicate the errors noted in the submissions to HRSA and request advice for how to correct this error.